ArticleCommunications biology2025

Engineered long-acting Irisin-albumin binding domain fusion protein for enhanced anti-inflammatory efficacy in lipopolysaccharide-induced systemic inflammation.

Jicun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.